68-5

95/120

Hum Genet, 2020; 65: 771-781. doi: 10.1038/s10038-020-0772-4. Epub 2020 May 13. PMID: 32398759. 46) Lin CH, Tsai PI, Lin HY, Hattori N, Funayama M, Jeon B, Sato K, Abe, K, Mukai Y, Taka‑hashi Y, Li Y, Nishioka K, Yoshino H, Daida K, Chen ML, Cheng J, Huang CY, Tzeng SR, Wu YS, Lai HJ, Tsai HH, Yen RF, Lee NC, Lo WC, Hung YC, Chan CC, Ke YC, Chao CC, Hsieh ST, Farrer MJ, Wu RM: Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism. Brain, 2020; 143: 3352-3373. 47) Masuzugawa S, Nishioka K, Imai Y, Ogata J, Shojima Y, Li Y, Yoshino H, Hattori N: A novel rare variant of LRRK2 associated with familial Parkinson’s disease: p.R1501W. Parkin‑sonism Relat Disord, 2020; 76: 46-48. doi:10. 1016/j.parkreldis.2020.05.035. Epub 2020 Jun 2. PMID: 32563051. 48) Miyamoto N, Magami S, Inaba T, Ueno Y, Hira K, Kijima C, Nakajima S, Yamashiro K, Urabe T, Hattori N: The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion. Glia, 2020; 68: 1910-1924. doi: 10.1002/glia.23814. 49) Miyamoto N, Ueno Y, Hira K, Kijima C, Naka‑jima S, Yamashiro K, Hattori N: Characteris‑tics of Clinical Symptoms, Cerebral Images and Stroke Etiology in Vertebro-Basilar Artery Fenestration-Related Infarction. Brain Sci, 2020; 10: 243. doi: 10.3390/brainsci10040243. PMID: 32326077; PMCID: PMC7226259. 50) Miyamoto N, Ueno Y, Hira K, Kijima C, Naka‑jima S, Yamashiro K, Nobutaka H: Character‑istics of clinical symptoms, cerebral images and stroke etiology in vertebra-basilar artery fenestration-related infarction. Brain Sci, 2020: 10: 243. 51) Miyazaki H, Yamanaka T, Oyama F, Kino Y, Kurosawa M, Yamada-Kurosawa M, Yamano R, Shimogori T, Hattori N, Nukina N: FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model. J Biol Chem, 2020; 295: 9768-9785. doi:10.1074/jbc.RA120.012983. 52) Mori A, Imai Y, Hattori N: Lipids; Key Players That Modulate α-Synuclein Toxicity and 53) Motoi Y, Hanger DP, Hasegawa M: Editorial: Tau Propagation Mechanisms: Cell Models, Animal Models, and Beyond. Front Neurosci, 2020; 14: 456. 54) Nakada S, Yamashita Y, Machida S, Miyagoe- Suzuki Y, Arikawa-Hirasawa E: Perlecan Facilitates Neuronal Nitric Oxide Synthase Delocalization in Denervation-Induced Muscle Atrophy. Cells, 2020; 9: 2524; https://doi.org/ 10.3390/cells9112524 55) Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, Hayashi N, Yokoi D, Watanabe H, Watanabe H, Katsuno M, Izumi Y, Kanai K, Hattori N, Morita M, Tani‑guchi A, Kano O, Oda M, Shibuya K, Kuwa‑bara S, Suzuki N, Aoki M, Ohta Y, Yamashita T, Abe K, Hashimoto R, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Okada Y, Ishihara T, Onodera O, Nakashima K, Kaji R, Kamatani Y, Ikegawa S, Momozawa Y, Kubo M, Ishida N, Minegishi N, Nagasaki M, Sobue G: A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun Biol, 2020; 3: 526. doi:10.1038/s42003-020-01251-2. 56) Nakano M, Riku Y, Nishioka K, Hasegawa M, Washimi Y, Arahata Y, Takeda A, Horibe K, Yamaoka A, Suzuki K, Tsujimoto M, Li Y, Yoshino H, Hattori N, Akagi A, Miyahara H, Iwasaki Y, Yoshida M: Unclassified four- repeat tauopathy associated with familial parkinsonism and progressive respiratory failure. Acta Neuropathol Commun, 2020; 8: 148. doi: 10.1186/s40478-020-01025-1. 57) Nakano M, Riku Y, Nishioka K, Hasegawa M, Washimi Y, Arahata Y, Takeda A, Horibe K, Yamaoka A, Suzuki K, Tsujimoto M, Li Y, Yoshino H, Hattori N, Akagi A, Miyahara H, Iwasaki Y, Yoshida M: Unclassified four‑re‑peat tauopathy associated with familial parkin‑sonism and progressive respiratory failure. Acta Neuropathol Commun, 2020; 8: 148. 58) Nakatani M, Matsumoto R, Kobayashi K, Hitomi T, Inouchi M, Matsuhashi M, Kinoshita M, Kikuchi T, Yoshida K, Kunieda T, Miya‑Neurodegeneration in Parkinson’s Disease. Int J Mol Sci, 2020; 21: 3301. doi: 10.3390/ijms21093301. PMID: 32392751; PMCID: PMC7247581.545